About The Medical Condition MDL17043

ClusterMed

Find the definition of the medical term MDL17043. MDL17043 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.

MDL17043

MDL17043 Medical Condition Defined & Explained
MDL17043 Medical Condition

What's The Definition Of The Medical Condition MDL17043?

1,3-Dihydro-4-methyl-5-(4-(methylthio)benzoyl)-2H-imidazol-2-one. A selective phosphodiesterase inhibitor with vasodilating and positive inotropic activity that does not cause changes in myocardial oxygen consumption. It is used in patients with congestive heart failure.

More Medical Conditions

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Medical Conditions Definitions Of The Day

  • Hospitals, Proprietary ‐ Hospitals owned and operated by a corporation or an individual…
  • Myxedemas, Congenital ‐ A condition due to congenital lack of thyroid hormone, marked…
  • Ketosuccinates ‐ Salts and esters of…
  • Cross Reaction ‐ Serological reactions in which an antiserum against one antigen…
  • Venoms, Scorpion ‐ Venoms from animals of the order Scorpionida of the class Arachnida.…
  • Neoplasms, Ureter ‐ Cancer or tumors of the URETER. Hematuria, which occurs in 75%…
  • Antagonists, Blood Platelet ‐ Drugs or agents which antagonize or impair any mechanism leading…
  • Carminomicin ‐ A very toxic anthracycline-type antibiotic related to DAUNORUBICIN,…
  • Elbow, Tennis ‐ A condition characterized by pain in or near the lateral humeral…
  • Tryptan ‐ An essential amino acid that is necessary for normal growth in…